• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依替膦酸二钠对合成尿液中结晶形成及草酸钙晶体与马-达二氏犬肾(MDCK)细胞黏附的影响。

Effects of etidronate disodium on crystallizations in synthetic urine and calcium oxalate crystal adhesion to Madin-Darby canine kidney (MDCK) cells.

作者信息

Ebisuno S, Kohjimoto Y, Nishikawa T, Nishihata M, Inagaki T, Komura T, Ohkawa T

机构信息

Division of Urology, Minami Wakayama National Hospital, Japan.

出版信息

Int J Urol. 1998 Nov;5(6):582-7. doi: 10.1111/j.1442-2042.1998.tb00416.x.

DOI:10.1111/j.1442-2042.1998.tb00416.x
PMID:9855128
Abstract

BACKGROUND

Several reports in the 1970s suggested that etidronate disodium might be clinically useful to prevent calcium stones, but the use of etidronate in the urolithiasis field was discontinued due to adverse effects of this drug on skeletal turnover and mineralization. Because the drug might affect not only crystallization, but also crystal-tubular interactions, we investigated the minimum dose of etidronate necessary to effectively prevent stone recurrence without adverse side effects.

METHODS

We examined the effect of etidronate on the crystallization of calcium oxalate, calcium phosphate and magnesium ammonium phosphate using synthetic urine and measured by an aggregometer. We also studied its effect on the adhesion of calcium oxalate monohydrate crystals to Madin-Darby canine kidney (MDCK) cells in vitro.

RESULTS

Etidronate affected the crystallization+ of not only calcium phosphate and calcium oxalate, but also magnesium ammonium phosphate in synthetic urine. The inhibitory activities on these crystallizations were detected at extremely low drug concentrations. Etidronate also had a strong inhibitory activity against the adhesion of calcium oxalate crystals to MDCK cells.

CONCLUSION

Although further studies are necessary regarding the effects of etidronate on crystallization and crystal adhesion both in vivo and in vitro, and the appropriate schedule of dosing to prevent side effects, it is possible that etidronate may be useful in the treatment of urinary stones.

摘要

背景

20世纪70年代的几份报告表明,依替膦酸二钠在临床上可能对预防钙结石有用,但由于该药物对骨骼周转和矿化的不良影响,其在尿路结石领域的使用已停止。由于该药物可能不仅影响结晶,还影响晶体与肾小管的相互作用,我们研究了有效预防结石复发且无不良副作用所需的依替膦酸最低剂量。

方法

我们使用合成尿液,通过凝聚仪检测依替膦酸对草酸钙、磷酸钙和磷酸镁铵结晶的影响。我们还在体外研究了其对一水合草酸钙晶体与Madin-Darby犬肾(MDCK)细胞粘附的影响。

结果

依替膦酸不仅影响合成尿液中磷酸钙和草酸钙的结晶,还影响磷酸镁铵的结晶。在极低的药物浓度下即可检测到对这些结晶的抑制活性。依替膦酸对草酸钙晶体与MDCK细胞的粘附也具有很强的抑制活性。

结论

尽管关于依替膦酸在体内和体外对结晶及晶体粘附的影响,以及预防副作用的适当给药方案仍需进一步研究,但依替膦酸可能对尿路结石的治疗有用。

相似文献

1
Effects of etidronate disodium on crystallizations in synthetic urine and calcium oxalate crystal adhesion to Madin-Darby canine kidney (MDCK) cells.依替膦酸二钠对合成尿液中结晶形成及草酸钙晶体与马-达二氏犬肾(MDCK)细胞黏附的影响。
Int J Urol. 1998 Nov;5(6):582-7. doi: 10.1111/j.1442-2042.1998.tb00416.x.
2
The effects of human urine on the adhesion of calcium oxalate crystal to Madin-Darby canine kidney cells.人尿液对草酸钙晶体与犬肾细胞系(Madin-Darby canine kidney cells)黏附的影响。
BJU Int. 1999 Jul;84(1):118-22. doi: 10.1046/j.1464-410x.1999.00103.x.
3
[The effects of human urine on the adhesion of calcium oxalate crystal to renal tubular cells].[人尿对草酸钙晶体与肾小管细胞黏附的影响]
Nihon Hinyokika Gakkai Zasshi. 1998 Dec;89(12):949-55. doi: 10.5980/jpnjurol1989.89.949.
4
Effect of bisphosphonates on the crystallization of stone-forming salts in synthetic urine.双膦酸盐对人工尿液中成石盐结晶的影响。
Investig Clin Urol. 2020 May;61(3):310-315. doi: 10.4111/icu.2020.61.3.310. Epub 2020 Apr 27.
5
Effect of Kampo extracts on urinary stone formation: an experimental investigation.汉方提取物对尿路结石形成的影响:一项实验研究。
Int J Urol. 2013 Oct;20(10):1032-6. doi: 10.1111/iju.12098. Epub 2013 Mar 25.
6
The effect of osteopontin on the adhesion of calcium oxalate crystals to Madin-Darby canine kidney cells.骨桥蛋白对草酸钙晶体与犬肾细胞黏附的影响。
Eur Urol. 1996;30(3):388-93. doi: 10.1159/000474201.
7
Modulatory effects of fibronectin on calcium oxalate crystallization, growth, aggregation, adhesion on renal tubular cells, and invasion through extracellular matrix.纤维连接蛋白对草酸钙结晶、生长、聚集、黏附在肾小管细胞上以及穿过细胞外基质侵袭的调节作用。
J Biol Inorg Chem. 2019 Mar;24(2):235-246. doi: 10.1007/s00775-019-01641-w. Epub 2019 Jan 30.
8
The effect of intracrystalline and surface-bound osteopontin on the attachment of calcium oxalate dihydrate crystals to Madin-Darby canine kidney (MDCK) cells in ultrafiltered human urine.晶体内部和表面结合的骨桥蛋白对二水草酸钙晶体在超滤液人尿中附着到 Madin-Darby 犬肾 (MDCK) 细胞的影响。
BJU Int. 2012 Apr;109(7):1100-9. doi: 10.1111/j.1464-410X.2011.10530.x. Epub 2011 Aug 24.
9
[Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].[依替膦酸二钠(EHDP)对合成1α(OH)维生素D3和乙二醇诱导的大鼠草酸钙肾结石的影响]
Hinyokika Kiyo. 1985 May;31(5):749-62.
10
Urinary turbidity as a marker of crystallization: is spectrophotometric assessment useful?尿浊度作为结晶的标志物:分光光度评估是否有用?
Int Urol Nephrol. 2013 Aug;45(4):1009-15. doi: 10.1007/s11255-013-0466-3. Epub 2013 May 15.

引用本文的文献

1
Effect of bisphosphonates on the crystallization of stone-forming salts in synthetic urine.双膦酸盐对人工尿液中成石盐结晶的影响。
Investig Clin Urol. 2020 May;61(3):310-315. doi: 10.4111/icu.2020.61.3.310. Epub 2020 Apr 27.
2
Inhibitory actions by ibandronate sodium, a nitrogen-containing bisphosphonate, on calcium-activated potassium channels in Madin-Darby canine kidney cells.含氮双膦酸盐伊班膦酸钠对马-达二氏犬肾细胞钙激活钾通道的抑制作用。
Toxicol Rep. 2015 Aug 28;2:1182-1193. doi: 10.1016/j.toxrep.2015.08.010. eCollection 2015.
3
Alendronate inhibits urinary calcium microlith formation in a three-dimensional culture model.
Urol Res. 2004 Jun;32(3):223-8. doi: 10.1007/s00240-004-0409-7. Epub 2004 Apr 3.
4
Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method.采用改良微量稀释法测定抗菌药物对纳米细菌的抑制作用。
Antimicrob Agents Chemother. 2002 Jul;46(7):2077-86. doi: 10.1128/AAC.46.7.2077-2086.2002.